Updated:
Chordoma Foundation
Josh Sommer established the Chordoma Foundation in 2007. The entity operates as a nonprofit dedicated to chordoma research and patient support.
Chordoma Foundation
Josh Sommer established the Chordoma Foundation in 2007. The entity operates as a nonprofit dedicated to chordoma research and patient support. The foundation directs resources toward laboratory research and clinical partnerships. It holds a US Treasury Bills portfolio. Board members include Christy Shaffer of Hatteras Venture Partners and Sue Mahony, former President of Lilly Oncology. Operations span the United States with additional facilities in Raleigh. The organization belongs to the TRAIN network of medical research foundations. It maintains affiliations with the Liddy Shriver Sarcoma Initiative and The Mark Foundation for Cancer Research. Oaz Nir provided a $7M+ gift in 2023.
General information
Firm type
Endowment / Foundation
Year founded
2007
Location
Region
North America
Country
United States
City
Durham
Corporate office
Durham, NC, United States
Additional offices
Raleigh, NC, United States
Principals
Josh Sommer
Co-founder and Executive Director
Christy Shaffer
Board member
Paul Feldman
Board member
Sue Mahony
Board member
Sector focus
Frequently asked questions
Who runs investment decisions at Chordoma Foundation?
Josh Sommer serves as Executive Director. The board includes professionals with venture capital and oncology experience.
Does Chordoma Foundation participate in fund commitments or only direct deals?
The foundation holds a US Treasury Bills portfolio and maintains research partnerships rather than traditional fund commitments.
Where does the underlying wealth come from?
The foundation relies on philanthropic donations, including a $7M+ gift from Oaz Nir in 2023.
How is Chordoma Foundation related to adjacent vehicles?
It operates Chordoma Foundation Labs at BioLabs North Carolina and maintains ties to sarcoma research initiatives.
What investment stages does Chordoma Foundation typically target?
The foundation focuses on research acceleration rather than staged venture or private equity investments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: